Horizon Technology Finance Corp. functions as a dedicated financial entity, primarily offering capital through secured lending to businesses supported by venture capital. ...
Horizon Technology Finance provides structured debt products tailored to the needs of growing technology, life science, healthcare information and services, and sustainability companies. These loans, which may include warrants or success fees, are designed to complement equity funding while minimizing dilution for founders and existing investors. The company leverages deep market expertise to provide capital with flexible structures, including meaningful interest-only periods.
Price Range: Transaction sizes up to $50 million.
Pain Points: High dilution associated with traditional equity funding, need for non-dilutive capital, and the requirement for flexible growth capital that aligns with unique startup growth patterns.
Solutions: Provides less dilutive growth capital, extends cash runway, supports acquisition strategies, and offers flexible repayment structures.
Target Users: Venture-backed high-growth companies in the technology, life science, healthcare information and services, and sustainability sectors.
Supply Chain
Venture capital-backed companiesEquity sponsorsMonroe Capital platformInstitutional and high net worth investor capital
Horizon provides term loans typically spanning 3-5 years, often featuring a significant interest-only period to assist companies in managing cash flow while they scale operations.
Price Range: Transaction sizes up to $50 million.
Pain Points: Short-term capital liquidity crunches and reliance on pure equity dilution.
Solutions: Predictable long-term financing that preserves equity ownership for management and early investors.
Target Users: Commercial-stage high-growth companies requiring capital to reach specific growth milestones.
Supply Chain
Venture capital-backed companies
These facilities are structured to provide immediate liquidity to growing firms, enabling them to continue their development path while waiting for anticipated venture capital infusions or other funding milestones.
Price Range: Transaction sizes up to $50 million.
Pain Points: Temporary liquidity shortfalls occurring between equity fundraising cycles.
Solutions: Ensures operational continuity and prevents premature dilution by providing essential capital before the next major funding event.
Target Users: High-growth firms currently in the process of closing or preparing for institutional equity financing.
Supply Chain
Venture capital-backed companies
These loans are structured to meet specific organizational needs, such as funding a strategic acquisition or financing equipment and R&D requirements for life science and technology companies.
Price Range: Transaction sizes up to $50 million.
Pain Points: Inability to fund large strategic initiatives using only existing cash reserves or equity.
Solutions: Provides targeted liquidity for specific growth-accelerating projects.
Target Users: Growth-stage companies undergoing rapid expansion or market entry.
